Skip to main content

Clinical and Translational Oncology

Ausgabe 12/2024

Inhalt (33 Artikel)

Research advances on TIL therapy for colorectal cancer

  • REVIEW ARTICLE

Jiaojiao Jiang, Wenxi Shu, Qinghua Yao

The role of IGF/IGF-1R signaling in the regulation of cancer stem cells

  • Review Article

Fengchao Liu, Susu Ye, Liu Zhao, Qinghui Niu

Biomarkers in breast cancer 2024: an updated consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

  • Open Access
  • REVIEW ARTICLE

Ramon Colomer, Blanca González-Farré, Ana Isabel Ballesteros, Vicente Peg, Begoña Bermejo, Belén Pérez-Mies, Susana de la Cruz, Federico Rojo, Sonia Pernas, José Palacios

Identification of SMC2 and SMC4 as prognostic markers in breast cancer through bioinformatics analysis

  • RESEARCH ARTICLE

Lili Pei, Yu Li, Hao Gu, Siqi Wang, Wenhao Wu, Siyi Fan, Xiao Shi, Xinxin Si

ITGB4 is a prognostic biomarker and correlated with lung adenocarcinoma brain metastasis

  • RESEARCH ARTICLE

Jingjing Zhang, Lingjie Li, Weiwei Luo, Shenglin Ma, Yanyan Zhao

Survival analysis in pT1-3 and paracolic lymph-node invasion colorectal cancer: the prognostic role of positive paracolic lymph-node ratio for adjuvant chemotherapy

  • RESEARCH ARTICLE

Xiaochuang Feng, Weilin Liao, Yuqing Tang, Xiaojiang Yi, Tieqiao Tian, Hongming Li, Jiaxin Lin, Xinquan Lu, Jin Wan, Jiahao Wang, Haijun Deng, Chuangqi Chen, Dechang Diao

Study of late toxicity biomarkers of locally advanced head and neck cancer patients treated with radiotherapy plus cisplatin or cetuximab points to the relevance of skin macrophages (TOX-TTCC-2015-01)

  • Open Access
  • RESEARCH ARTICLE

Antonio Rullan, Juan A. Marín-Jiménez, Alicia Lozano, Oriol Bermejo, Lorena Arribas, Nuria Ruiz, Isabel Linares, Miren Taberna, Xavi Pérez, María Plana, Marc Oliva, Ricard Mesía

The value of combined MRI, enhanced CT and 18F-FDG PET/CT in the diagnosis of recurrence and metastasis after surgery for ovarian cancer

  • RESEARCH ARTICLE

Yong Hong, Jianfeng Peng, Yanni Zeng, Xuewen Deng, Wanjun Xu, Juanting Wang

MKI67 with arterial hypertension predict a poor survival for prostate cancer patients, a real-life investigation

  • RESEARCH ARTICLE

Yongqiang Zhou, Weihai Chen, Hao Jiang, Yuke Zhang, Zheng Ma, Zhenfan Wang, Chen Xu, Minjun Jiang, Jianchun Chen, Zhijun Cao

Different genetic profiles contribute to worse overall survival in patients with leptomeningeal metastases of non-small-cell lung cancer

  • RESEARCH ARTICLE

Xusheng Tang, Xiaojuan Hu, Lin Yuan, Hainan Yang, Yunfen Luo, Da Liu, Qingjun Hu, Changguo Shan, Tao Lin, Linbo Cai, Zhaoming Zhou, Xin Jin, Ming Lei, Weiping Hong

Almonertinib and alflutinib show novel inhibition on rare EGFR S768I mutant cells

  • RESEARCH ARTICLE

Xiangkai Wei, Guoliang Zhang, Qian Liu, Zhiyuan Niu, Chunhong Chu, Chenxue Liu, Ke Wang, Lanxin Li, Rui Wang, Wenrui Cui, Huixia Xu, Chenyang Liu, Ying Wang, Lei An

Early diagnostic value of ECT whole-body bone imaging combined with PINP and β-CTX for bone metastasis of lung cancer

  • Research Article

Meiying Jiang, Qiyun Yu, Haitao Mei, Yingchao Jian, Rong Xu

Retrospective registry of patients with locally advanced/metastatic HR+/HER2− breast cancer treated in clinical practice in Andalusia

  • Open Access
  • RESEARCH ARTICLE

Natalia Chavarría Piudo, Isabel Blancas, Encarna González Flores, Fernando Henao Carrasco, Pilar López Álvarez, David Morales Pancorbo, Salvador Gámez Casado, María de la Cabeza Lomas Garrido, José Manuel Rodríguez García, Antonia Martínez Guisado, Adrián Sánchez Vega, Manuel Ruíz Borrego

Clinical effects of re-evaluating a lung SBRT failure mode and effects analysis in a radiotherapy department

  • RESEARCH ARTICLE

Sergi Benavente, Alexandra Giraldo, Alejandro Seoane, Mónica Ramos, Ramona Vergés

LC–MS metabolomics analysis of serum metabolites during neoadjuvant chemoradiotherapy in locally advanced rectal cancer

  • RESEARCH ARTICLE

Qiliang Peng, Lili Jiang, Yi Shen, Yao Xu, Xinan Shen, Li Zou, Yaqun Zhu, Yuntian Shen

Constructing a prognostic model for colorectal cancer with synchronous liver metastases after preoperative chemotherapy: a study based on SEER and an external validation cohort

  • Open Access
  • RESEARCH ARTICLE

Yixin Ding, Xiaoxi Han, Shufen Zhao, Shasha Wang, Jing Guo, Chuanyu Leng, Xiangxue Li, Kongjia Wang, Wensheng Qiu, Weiwei Qi

Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line

  • Open Access
  • Research Article

Jaime Espinós, José Manuel Aramendía, Antonio González-Martín, Marta Santisteban, Luisa Sánchez, Ángel Vizcay, José Ángel Mínguez, Juan Luis Alcázar

Advanced non-squamous NSCLC with no actionable oncogenic driver in Spain: a cross-sectional descriptive analysis of data from the Thoracic Tumor Registry

  • RESEARCH ARTICLE

Enric Carcereny, Delvys Rodriguez-Abreu, Rafael Lopez, Fabio Franco, Maria Guirado, Bartomeu Massutí, Manuel Cobo, Ana Blasco, Guillermo Suay, Edel del Barco, Ana Laura Ortega, Maria Angeles Sala, Patricia Cordeiro, Reyes Bernabé, José Luís González Larriba, Joaquim Bosch-Barrera, Julia Calzas, Joaquín Casal, Airam Padilla, Alfredo Sánchez-Hernandez, Mariano Provencio

Thrombosis and infections associated with PICC in onco-hematological patients, what is their relevance?

  • RESEARCH ARTICLE

Manuel Sánchez Cánovas, Esmeralda García Torralba, Noel Blaya Boluda, Ana Sánchez Saura, Gabriel Puche Palao, Ana Sánchez Fuentes, Lorena Martínez Montesinos, Carmen Poveda Ganga, Lucía García Tomas, Josefa Bayona Jiménez, Ángeles Cos Zapata, Carmen María Muñoz Jurado, Inmaculada Pina Mingorance, María Amor Caravaca Hernández, Vicente Vicente García, Francisco Ayala de la Peña

The clinical features and prognostic implications of the co-mutated TP53 gene in advanced non-small cell lung cancer

  • Research Article

Bing Bai, Xia An, Qinghui Qu, Xin Liu, Yuanyuan Liu, Li Wei

Stereotactic ablative radiotherapy (SABR) for patients with lung tumor and severe pulmonary function impairment

  • RESEARCH ARTICLE

Abraham André Arturo Geng-Cahuayme, Blanca Peregrín-Pastor, Mónica Ramos-Albiac, Enar Recalde-Vizcay, Juan Sebastián Parada-Zuluaga, Jordi Giralt-López de Sagredo, Xavier Maldonado-Pijoan, Alexandra Giraldo-Marín

Value of circulating tumor cell assisting low-dose computed tomography in screening pulmonary nodules based on existing liquid biopsy techniques: a systematic review with meta-analysis and trial sequential analysis

  • Research Article

Yixian Wang, Yuqing Duan, Dingjie Guo, Hongbo Lv, Qiong Li, Xuan Liu, Na Qiao, Hengyu Meng, Xin Zhang, Linwei Lan, Xiumin Liu, Xin Liu

Hyperprogressive disease in patients with advanced cancer treated with immune checkpoint inhibitors

  • RESEARCH ARTICLE

Gülin Alkan Şen, Nihan Şentürk Öztaş, Ezgi Değerli, Murad Guliyev, Günay Can, Hande Turna, Mustafa Özgüroğlu

Neu im Fachgebiet Onkologie

Dänische Zwillingsstudie deutet auf erhöhtes Krebsrisiko bei Tätowierten hin

Haben Tattoo-Träger und -Trägerinnen ein erhöhtes Risiko, an Hautkrebs oder einem Lymphom zu erkranken? Die Ergebnisse einer Zwillingsstudie aus Dänemark scheinen dafür zu sprechen. Die Forschungsgruppe rät vorerst zur Zurückhaltung beim Tätowieren.

Weniger PSA-Screening, mehr fortgeschrittene Tumoren

Eine Empfehlung gegen das Prostatakrebs-Screening, die mehrere Jahre in den Leitlinien des Royal Australasian College of General Practitioners gegeben wurde, hat sich nicht nur auf die Rate von PSA-Tests negativ ausgewirkt.

Schützt kutane Autoimmunität vor Hauttumoren?

Schwedische Registerdaten deuten auf ein geringeres Risiko für bestimmte Hauttumoren bei Personen mit Vitiligo oder autoimmuner Alopezie. Wie es dazu kommt, ist dagegen unklar.

Muss man wirklich auch die letzte Krebszelle eliminieren?

Genauere Prognoseabschätzung, bessere Therapiesteuerung und eine schnellere Entwicklung innovativer Behandlungsansätze – der Messung der minimalen Resterkrankung (MRD) wird ein enormes Potenzial attestiert. Eine Übersichtsarbeit unterstreicht jetzt aber: Es gibt noch blinde Flecken.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.